Home⇛International Journal of Multidisciplinary: Applied Business and Education Research⇛vol. 4 no. 12 (2023)

Potential Association of Strongyloides stercoralis and its effectivity against Type 2 Diabetes Mellitus: A Systematic Review of Scientific Attestation

Jean A. Alimpolos | Christian Ray A. Martinez |  Navy May G. Morris | Roel Nickelson P. Solano

 

Abstract:

The association of Strongyloides stercoralis in Type 2 Diabetes mellitus has put on a spotlight on various researchers after the discovery of S. stercoralis's capability to conduct immunomodulation through lowering the production and release of cytokines, all of which provide a contradictory action towards the development of T2DM. T2DM results from a high number of macrophages that secrete cytokines and chemokines abnormally, which affects the B-pancreatic cells and leads to insulin resistance. However, regardless of this information, the linkage of the immunomodulation mechanism of S. stercoralis infection against T2DM still needs clarification and further validation. Thus, this systematic review was conceptualized to identify if there is a direct association between S. stercoralis and T2DM, including the effects of the helminth on patients with such a disease, and the underlying factors related to this relationship. Studies for the review were collected in the following databases: PubMed, ProQuest, Wiley, Open Access Theses and Dissertations (OATD), Internet Archive Scholars, and Elsevier. The 2020 Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) criteria was utilized to identify and screen eligible studies for review and among the chosen articles, three have suggested a direct association between S. stercoralis infection and T2DM, while two studies proved the absence of an association by statistical and clinical characteristics. These limited findings and conflicting evidence for a direct link between S. stercoralis and T2DM may indicate that the comorbidity of both factors points more toward an indirect relationship.



References:

  1. Htun NS, Odermatt P, Paboriboune P, et al. Association between helminth infec-tions and diabetes mellitus in adults from the Lao People’s Democratic Re-public: A cross-sectional study. Infec-tious Diseases of Poverty. 2018;7(1). doi:10.1186/s40249-018-0488-2
  2. Rajamanickam A, Munisankar S, Bhootra Y, et al. Metabolic consequences of concomitant strongyloides stercoralis infection in patients with type 2 diabetes mellitus. Clinical Infectious Diseases. 2018;69(4):697-704. doi:10.1093/cid/ciy935
  3. Thibault, Véronique, et al. Factors that could Explain the Increasing Prevalence of Type 2 Diabetes among Adults in a Canadian province: a critical review and analysis. 2016.Biomedcentral: Diabetology & Metabolic Syndrome. https://dmsjournal.biomedcentral.com/articles/10.1186/s13098-016-0186-9#Tab1
  4. National Diabetes Statistics Report. Centers for Disease Control and Prevention. 2022. [ https://www.cdc.gov/diabetes/data/statisti csreport/index.html ] November 12, 2022
  5. Hotez PJ, Alvarado M, Basáñez M-G, et al. The global burden of disease study 2010: Interpretation and implications for the neglected tropical diseases. PLoS Neglected Tropical Diseases. 2014;8(7). doi:10.1371/journal.pntd.0002865
  6. Soil-transmitted helminth infections. World Health Organization. 2022. [ https://www.who.int/news-room/fact-sheets/detail/soil-transmitted-helminth-infections ] November 12, 2022
  7. Shen S-W, Lu Y, Li F, et al. The potential long-term effect of previous schistosome infection reduces the risk of metabolic syndrome among Chinese men. Parasite Immunology. 2015;37(7):333-339. doi:10.1111/pim.12187
  8. Nutman TB. Human infection with Strongyloides stercoralisand other related Strongyloides species. Parasitology. 2016;144(3):263-273. doi:10.1017/s0031182016000834
  9. Silas E, Ndlovu S, Tshilwane SI, Mukaratirwa S. Immunological and patho-physiological outcomes of helminth in-fections and type 2 diabetes comorbidity studies in humans and experimental animals—a scoping review. Applied Sciences. 2021;11(17):8079. doi:10.3390/app11178079
  10. Daniele, G.; Mendoza, R.G.; Winnier, D.; Fiorentino, T.V.; Pengou, et al. The inflammatory status score including IL-6, TNF-α, osteopontin, fractalkine, MCP-1 and adiponectin underlies whole-body insulin resistance and hypergly-cemia in type 2 diabetes mellitus. Acta Diabetol. 2013, 51, 123–131.
  11. Wu, Y.; Ding, Y.; Tanaka, Y.; Zhang, W. Risk factors contributing to type 2 diabe-tes and recent advances in the treatment and prevention. Int. J. Med. Sci. 2014, 11, 1185–1200.
  12. Doenhoff MJ, Stanley RG, Griffiths K, Jackson CL. An anti-atherogenic effect of schistosoma mansoni infections in mice associated with a parasite-induced lowering of blood total cholesterol. Parasitology. 2002;125(5):415-421. doi:10.1017/s0031182002002275
  13. Zinsou JF, Janse JJ, Honpkehedji YY, et al. Schistosoma haematobium infection is associated with lower serum cholester-ol levels and improved lipid profile in overweight/obese individuals. PLOS Neglected Tropical Diseases. 2020;14(7). doi:10.1371/journal.pntd.0008464
  14. Sanya RE, Webb EL, Zziwa C, et al. The effect of helminth infections and their treatment on metabolic outcomes: Re-sults of a cluster-randomized trial. Clinical Infectious Diseases. 2019;71(3):601-613. doi:10.1093/cid/ciz859
  15. Yingklang M, Chaidee A, Dangtakot R, Jantawong C, Haonon O, Sitthirach C, et al. Association of Strongyloides stercoralis infection and type 2 diabetes mellitus in northeastern Thailand: Impact on diabet-ic complication-related renal biochemical parameters. PLoS ONE. 2022; 17(5): e0269080. doi: 10.1371/journal. pone.0269080
  16. Rajamanickam A, Munisankar S, Menon PA, Nutman TB, Babu S. Diminished circulating levels of angiogenic factors and rage ligands in helminth–diabetes comorbidity and reversal following anthelmintic treatment. The Journal of Infectious Diseases. 2021;224(9):1614-1622. doi:10.1093/infdis/jiab170
  17. Hübner MP, Shi Y, Torrero MN, et al. Helminth protection against autoim-mune diabetes in nonobese diabetic mice is independent of a type 2 immune shift and requires TGF-β. The Journal of Immunology. 2011;188(2):559-568. doi:10.4049/jimmunol.1100335
  18. Taira K, Yazawa R, Watanabe A, et al. Syphacia muris infection delays the onset of hyperglycemia in WBN/KOB-lepr fa rats, a new type 2 diabetes mellitus model. Helminthologia. 2015;52(1):58-62. doi:10.1515/helmin-2015-0010
  19. Hays R, Esterman A, Giacomin P, Loukas A, McDermott R. Does Strongyloides stercoralis infection protect against type 2 diabetes in humans? evidence from australian aboriginal adults. Diabetes Research and Clinical Practice. 2015;107(3):355-361. doi:10.1016/j.diabres.2015.01.012
  20. Talukder MR, Pham H, Woodman R, et al. The association between diabetes and human T-cell leukaemia virus type-1 (HTLV-1) with Strongyloides ster-coralis: Results of a community-based, cross-sectional survey in Central Australia. International Journal of Envi-ronmental Research and Public Health. 2022;19(4):2084. doi:10.3390/ijerph19042084
  21. Ottesen EA, Hiatt RA, Cheever AW, Sotomayor ZR and Neva FA. The acquisition and loss of antigen-specific cellular immune responsiveness in acute and chronic schistosomiasis in man. Clin Exp Immunol 1978; 33: 37-47.
    Allen JE and Maizels RM. Diversity and dialogue in immunity to helminths. Nat Rev Immunol 2011; 11: 375-388.
  22. de Ruiter K, Tahapary DL, Sartono E, et al. Helminths, hygiene hypothesis and type 2 diabetes. Parasite Immunol. 2017;39(5):10.1111/pim.12404. doi:10.1111/pim.12404
  23. Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for System-atic Reviews of Interventions. 2nd Edi-tion. Chichester (UK): John Wiley & Sons, 2019.
  24. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systemat-ic reviews. BMJ 2021;372:n71. doi: 10.1136/bmj.n71.
  25. Salvador, Fernando, et al. “Imported Strongyloides Stercoralis Infection and Diabetes Mellitus and Other Metabolic Diseases: Is There Any Association?” Tropical Medicine & International Health, vol. 28, no. 3, 2023, pp. 232–236, https://doi.org/10.1111/tmi.13853.
  26. Rajamanickam, Anuradha, et al. “Helminth Infection Modulates Systemic Pro-Inflammatory Cytokines and Chemokines Implicated in Type 2 Diabetes Mellitus Pathogenesis.” PLOS Neglected Tropical Diseases, vol. 14, no. 3, 2020, https://doi.org/10.1371/journal.pntd.0008101.
  27. Hays, Russell, et al. “The Relationship between Treatment for Strongyloides Stercoralis Infection and Type 2 Diabetes Mellitus in an Australian Aboriginal Population: A Three-Year Cohort Study.” Diabetes Research and Clinical Practice, vol. 134, 2017, pp. 8–16, https://doi.org/10.1016/j.diabres.2017.09.012.
  28. Meshkani, Reza, and Sanaz Vakili. “Tissue resident macrophages: Key players in the pathogenesis of type 2 diabetes and its complications.” Clinica chimica acta; international journal of clinical chemistry vol. 462 (2016): 77-89. doi:10.1016/j.cca.2016.08.015

Tools


Copyright © 2024  KITE Digital Educational Solutions |  Exclusively distributed by CE-Logic